 |
|
|
| |
Ledipasvir/Sofosbuvir Fixed-Dose Combination Is Safe and Efficacious in Cirrhotic Patients Who Have Previously Failed Protease-Inhibitor Based Triple Therapy
|
| |
| |
Reported by Jules Levin
AASLD 2014 Nov 7-11 Boston
Marc Bourliere,1 Jean-Pierre Bronowicki,2 Victor de Ledinghen,3 Christophe Hézode,4 Fabien Zoulim,5 Philippe Mathurin,6 Albert Tran,7 Dominique G. Larrey,8 Vlad Ratziu,9 Laurent Alric,10 Robert H. Hyland,11 Deyuan Jiang,11 Brian Doehle,11 Phillip S. Pang,11 William T. Symonds,11 Mani Subramanian,11 John G. McHutchison,11 Patrick Marcellin,12 François Habersetzer,13 Dominique Guyader,14 Jean-Didier Grange,15 Veronique Loustaud-Ratti,16 Lawrence Serfaty,17 Sophie Metivier,18 Vincent Leroy,19 Armand Abergel,20 Stanislas Pol21
1Hopital Saint Joseph, Marseilles, France; 2CHU de Nancy-Hopital Brabois Adulte, Vandoeuvre-les-Nancy, France; 3CHU de Bordeaux, Pessac, France; 4Hopital Henri Mondor, Créteil, France; 5Hopital de La Croix Rousse, Lyon, France; 6CHRU Lille, Lille, France; 7CHU de Nice, Nice, France; 8Hopital Saint Eloi, Montpellier, France; 9Hopital de la Pitié Salpétriere, Paris, France; 10Hopital Purpan, Toulouse, France; 11Gilead Science, Inc., Foster City, CA; 12Hopital Beaujon, Clichy, France; 13Hopitaux Universitaires de Strasbourg, Strasbourg, France; 14Hopital Pontchaillou, Rennes, France; 15Hopital Tenon, Paris, France; 16Hopital Universitaire Dupuytren, Limoges, France; 17Hopital Saint Antoine, Paris, France; 18Hopital Purpan, Toulouse, France; 19CHU de Grenoble, Grenoble, France; 20CHU Estaing, Clermont-Ferrand, France; 21Department of Hepatology, Hopital Cochin et Université Paris-René Descartes, Paris, France
|
| |
|
|
|
|
|
